Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2024-08-29 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, share issues, and closing balances. The document is a regulatory disclosure about share capital changes rather than a financial report or earnings release. It is not a full annual or interim report, nor a management discussion or audit report. It is a formal notification of share capital changes, fitting the category of Share Issue/Capital Change filings. The document length (8923 characters) and detailed tabular data support this classification rather than a brief announcement or a report publication notice.
2024-08-29 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 100% confidence The document is a list of directors and their roles and functions for Transcenta Holding Limited, including details about board committees. It does not contain financial data, audit results, or meeting results. It is an announcement related to board/management information, specifically about the composition and roles of the board of directors. The document length is short (1201 characters), and it is not a report or presentation but a formal announcement of board members and their committee memberships. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-08-28 English
(1) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024&#x3b; (2) CHANGE IN USE OF PROCEEDS&#x3b; (3) APPOINTMENT OF NON-EXECUTIVE DIRECTOR&#x3b; AND (4) CHANGE IN THE COMPOSITION OF B
Interim / Quarterly Report Classification · 100% confidence The document is an announcement from Transcenta Holding Limited regarding their unaudited consolidated interim financial results for the six months ended June 30, 2024. It includes detailed financial highlights, business updates, clinical program achievements, and management discussion and analysis for the half-year period. The presence of actual financial data, operational performance, and management commentary for a period shorter than a full fiscal year clearly indicates this is an Interim / Quarterly Report. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-28 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of Transcenta Holding Limited about the date of a board meeting scheduled to consider and approve the interim results for the six months ended June 30, 2024, and possibly recommend an interim dividend. The document does not contain any financial data or the actual interim report itself, but rather announces the upcoming meeting where such results will be discussed. The document length is short (1498 characters) and it is clearly an announcement, not the report itself. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement about a board meeting and upcoming interim results, rather than the Interim / Quarterly Report (IR) itself or a Report Publication Announcement (RPA) since it does not mention the report being published or attached.
2024-08-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report submitted to the Hong Kong Exchanges and Clearing Limited regarding movements in securities for Transcenta Holding Limited. It includes detailed information on authorized share capital, issued shares, treasury shares, share options, repurchases, and confirmations related to compliance with listing rules. The document is structured as a regulatory return concerning share capital and share movements, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a substantive regulatory filing with detailed data on share capital changes. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-08-06 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed tables of share repurchases, dates, prices, and confirmations of compliance with listing rules. The content is focused on reporting share repurchase activities and changes in share capital rather than financial results, management changes, or other report types. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, not just an announcement or a brief notice, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is POS.
2024-07-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.